The integration of chemotherapy into a combined modality approached to cancer therapy. V. Squamous cell cancer of the head and neck.
D001761:Bleomycin / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005472:Fluorouracil / Q000627:therapeutic use; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007822:Laryngeal Neoplasms / Q000188:drug therapy; D002955:Leucovorin / Q000627:therapeutic use; D008048:Lip Neoplasms / Q000188:drug therapy; D008207:Lymphatic Metastasis; D008727:Methotrexate / Q000627:therapeutic use; D009062:Mouth Neoplasms / Q000188:drug therapy; D009303:Nasopharyngeal Neoplasms / Q000188:drug therapy; D014062:Tongue Neoplasms / Q000188:drug therapy
D001761:Bleomycin; D002955:Leucovorin; D005472:Fluorouracil; D006918:Hydroxyurea; D008727:Methotrexate